Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Sophie Tassan-Mangina"'
Autor:
Adèle Lérault, Aurélien Villecourt, Thibaud Decottignies-Dienne, Sophie Tassan-Mangina, Virginie Heroguelle, Alessandro Di Cesare, Sylvain Rubin, Vito Giovanni Ruggieri, Damien Metz, Laurent Faroux
Publikováno v:
Archives of Cardiovascular Diseases. 116:117-125
Autor:
Pierre Nazeyrollas, Vito G. Ruggieri, Laurent Faroux, Sophie Tassan-Mangina, A Muneaux, A. Poncet, V. Heroguelle, Damien Metz, A. Villecourt
Publikováno v:
European Heart Journal. 41
Transcarotid (TC) and transsubclavian (TSc) accesses are increasingly used as alternative approaches for TAVI when the transfemoral (TF) access is not suitable. However, concerns remain about the risk of peri-procedural stroke and long-term outcomes
Autor:
Josep Rodés-Cabau, Laurent Faroux, Eric Dumont, Dimitri Kalavrouziotis, Lucia Junquera, David del Val, Jean-Michel Paradis, Robert DeLarochellière, Thierry Blanpain, Jean Arsenault, Aurélien Villecourt, Damien Metz, Jérôme Wintzer-Wehekind, Virginie Heroguelle, Siamak Mohammadi, Vito Giovanni Ruggieri, Leonardo Guimaraes, Sophie Tassan-Mangina, Guillem Muntané-Carol
Publikováno v:
The Annals of thoracic surgery. 111(5)
BACKGROUND The impact of novel alternative access and valve type on radiation exposure during transcatheter aortic valve replacement (TAVR) has not yet been evaluated. This study sought to determine the impact of a transarterial approach and prosthes
Autor:
Sophie Moumen, Yves-Assad Saade, Sophie Tassan-Mangina, Laurent Faroux, Victor Oudin, Damien Metz
Publikováno v:
La Presse Médicale. 48:989-991
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 13:254
Introduction We aimed to detect early atrial morphologic and functional changes after successful electric cardioversion of atrial fibrillation (AF) and to correlate them to alterations of left and right ventricular strain Method All patients with suc
Autor:
Pierre Nazeyrollas, Laurent Faroux, Sophie Tassan-Mangina, Caroline Mora, M. Kinnel, T. Blanpin, Damien Metz, A. Villecourt, V. Heroguelle
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 12:85-86
Background X-rays are widely used for the TAVR realization, for the pre-TAVR assessment (coronary angiography ± PCI and computed tomography), and sometimes in the aftermath of the intervention (electrophysiology study, pacemaker implantation). TAVR
Autor:
Thierry Blanpain, Sophie Tassan-Mangina, Pierre Nazeyrollas, Christophe Tourneux, Virginie Heroguelle, Florian Baudin, Damien Metz, Laurent Faroux
Publikováno v:
International Journal of Cardiology. 259:57-59
Exposure of operators to ionising radiation in interventional cardiology has likely diminished, but data confirming the magnitude of the reduction are lacking. The aim of this study was to compare the dose of radiation received by interventional card
Autor:
Laurent Faroux, Anne Poncet, Sophie Tassan-Mangina, Alexandre Muneaux, Aurélien Villecourt, Damien Metz, Virginie Heroguelle, Pierre Nazeyrollas, Vito Giovanni Ruggieri
Publikováno v:
Archives of cardiovascular diseases. 113(3)
Summary Background Transcarotid and trans-subclavian access routes are increasingly used as alternative approaches for transcatheter aortic valve implantation (TAVI) when transfemoral access is not suitable. However, concerns remain about the risk of
Autor:
Marine Kinnel, Sophie Tassan-Mangina, Caroline Mora, Laurent Faroux, Thierry Blanpain, Pierre Nazeyrollas, Aurélien Villecourt, Virginie Heroguelle, Damien Metz
Publikováno v:
The American journal of cardiology. 125(1)
Transcatheter aortic valve implantation (TAVI) is currently becoming an alternative to surgical valve replacement for patients at low risk, a population that is likely to experience an increase in the radiation-induced cancer risk following TAVI. We
Autor:
Aurélien Villecourt, Laurent Faroux, Virginie Heroguelle, Damien Metz, Marine Kinnel, Pierre Nazeyrollas, Vito Giovanni Ruggieri, Sophie Tassan-Mangina, Anne Poncet
Publikováno v:
Archives of cardiovascular diseases. 113(3)
Summary Background Transcatheter aortic valve replacement is now indicated in patients at intermediate surgical risk and will probably soon be indicated in patients at low surgical risk, for whom the occurrence of serious procedural complications is